BTLA/CD272 Rekombinanter Antikörper

BTLA/CD272 Rekombinant Antikörper für WB, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Maus

Anwendung

WB, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

242133E5

Kat-Nr. : 84754-5-PBS

Synonyme

242133E5, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, Btla, CD272



Geprüfte Anwendungen

Produktinformation

84754-5-PBS bindet in WB, IF/ICC, Indirect ELISA BTLA/CD272 und zeigt Reaktivität mit Maus

Getestete Reaktivität Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen BTLA/CD272 fusion protein Eg1843
Vollständiger Name B and T lymphocyte associated
Berechnetes Molekulargewicht34kDa
Beobachtetes Molekulargewicht50 kDa
GenBank-ZugangsnummerAAI08964.1
Gene symbol Btla
Gene ID (NCBI) 208154
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

BTLA, or B and T lymphocyte attenuator, is a member of the CD28 superfamily and is a type I membrane glycoprotein identified as an inhibitory receptor (PMID: 33859648). BTLA is extensively expressed in lymph nodes, thymus, and spleen, with little or no expression in organs such as the heart, kidney, brain, and liver (PMID: 33859648). Among immune cells, BTLA is primarily expressed in B and T cells, with higher expression in B cells compared to T cells in the mouse spleen (PMID: 33859648). BTLA plays a crucial role in regulating stimulatory and inhibitory signals in immune responses.